As a membrane-embedded protein component, frdD exhibits distinct biochemical properties that facilitate its anchoring function. The recombinant form is typically stored in a Tris-based buffer containing 50% glycerol, specifically optimized to maintain protein stability . Storage recommendations include keeping the protein at -20°C, with extended storage at -20°C or -80°C as needed. Working aliquots may be maintained at 4°C for up to one week, though repeated freezing and thawing cycles should be avoided to preserve protein integrity .
The primary structure of P. multocida frdD reveals a protein rich in hydrophobic amino acids, consistent with its role as a membrane anchor for the fumarate reductase complex. Sequence analysis indicates multiple transmembrane domains that facilitate integration into the bacterial membrane, providing stability to the entire enzyme complex. These hydrophobic regions likely form alpha-helical structures that span the lipid bilayer, positioning the catalytic components of the complex appropriately for electron transfer.
The frdD gene exists within a larger operon structure that typically includes all components of the fumarate reductase complex. This genetic organization ensures coordinated expression of the entire enzyme complex under appropriate metabolic conditions. In P. multocida, the fumarate reductase genes are likely regulated in response to oxygen availability, with increased expression under anaerobic or microaerobic conditions that necessitate alternative electron acceptors like fumarate.
The primary function of the fumarate reductase complex, including its frdD subunit, is to enable anaerobic respiration by catalyzing the reduction of fumarate to succinate. This reaction represents a critical step in anaerobic electron transport, allowing bacteria to generate energy in oxygen-limited environments. The frdD subunit specifically serves to anchor the catalytic components of the enzyme complex to the bacterial membrane, facilitating appropriate spatial organization for efficient electron transfer.
In related bacterial species such as Actinobacillus pleuropneumoniae, the frdD gene (APL_1526) has been shown to be upregulated under specific conditions with a fold change of 2.178 . This differential expression highlights the metabolic importance of fumarate reductase components across bacterial species, suggesting similar regulatory mechanisms may operate in P. multocida.
While direct evidence linking frdD specifically to P. multocida virulence is limited in the current literature, the ability to perform anaerobic respiration represents an important adaptation for bacterial survival within host tissues. Recent pathogenomic analyses of P. multocida strains isolated from human infections have revealed various virulence factors and mobile genetic elements , suggesting complex adaptive mechanisms enable this organism to colonize and infect host tissues. The capacity for anaerobic respiration facilitated by components like frdD likely contributes to bacterial persistence in oxygen-restricted microenvironments encountered during infection.
The production of recombinant P. multocida frdD typically involves heterologous expression systems, with bacterial hosts like Escherichia coli being commonly employed. The expression construct generally incorporates affinity tags to facilitate downstream purification, though the specific tag type may vary depending on the production process . Expression typically encompasses the full protein sequence (amino acids 1-116) to ensure complete structural and functional integrity .
Purification of recombinant frdD presents unique challenges due to its hydrophobic, membrane-associated nature. Affinity chromatography represents the primary purification method, leveraging incorporated tags for selective binding. Following purification, quality control measures typically include SDS-PAGE analysis to confirm protein integrity and size, with additional functional assays as needed to verify activity within reconstituted enzyme complexes.
Recombinant frdD serves as an antigen for antibody production, enabling the development of detection methods for P. multocida. ELISA (Enzyme-Linked Immunosorbent Assay) systems utilizing recombinant frdD are available for research purposes , allowing sensitive and specific detection of antibodies against this protein in various sample types. Such immunological tools facilitate both basic research and potential diagnostic applications.
Understanding the structure and function of bacterial fumarate reductase components, including frdD, creates opportunities for developing targeted antimicrobial strategies. Since mammals do not use fumarate as a terminal electron acceptor in energy metabolism, inhibitors specifically targeting bacterial fumarate reductase could potentially offer selective antimicrobial activity with minimal host toxicity. This approach may prove particularly valuable given the increasing prevalence of antibiotic resistance among bacterial pathogens.
The fumarate reductase complex represents one of several terminal reductases that facilitate bacterial anaerobic respiration. While functionally related to enzymes like nitrate reductase (NrfC) and dimethylsulfoxide reductase (DmsA), which were observed to have fold changes of 2.250 and 1.934 respectively in A. pleuropneumoniae , fumarate reductase occupies a distinct role in the utilization of fumarate as an electron acceptor. The differential regulation of these various terminal reductases likely reflects adaptation to specific environmental niches and substrate availability.
Fumarate reductase components, including frdD, show evolutionary conservation across diverse bacterial species, reflecting the fundamental importance of anaerobic respiration in bacterial survival and adaptation. Comparative genomic analyses reveal both conserved domains essential for core functionality and species-specific variations that may reflect adaptation to particular ecological niches or host environments.
Further investigation of the regulatory mechanisms controlling frdD expression in P. multocida under various environmental conditions would enhance understanding of how this pathogen adapts to changing oxygen availability during infection. Such studies might reveal potential intervention points for disrupting bacterial adaptation to host environments.
The distinct role of fumarate reductase in bacterial metabolism presents an opportunity for developing targeted antimicrobial agents. Structure-guided design of small molecule inhibitors specifically targeting components of the fumarate reductase complex could potentially yield novel therapeutic approaches for combating P. multocida infections in both veterinary and human medicine.
KEGG: pmu:PM0198
STRING: 272843.PM0198
The fumarate reductase complex is fundamentally important for P. multocida's ability to grow and survive under anaerobic or oxygen-limited conditions. This enzyme:
Performs the terminal step in anaerobic respiration by using fumarate as the final electron acceptor
Catalyzes the reduction of fumarate to succinate while oxidizing quinol to quinone
Enables energy generation via electron transport phosphorylation in the absence of oxygen
Functions in the opposite direction of succinate dehydrogenase, which operates in aerobic conditions
Research has demonstrated that fumarate is an essential terminal electron acceptor during anaerobic respiration in Pasteurellaceae. In A. pleuropneumoniae (a related organism in the same family), disruption of fumarate metabolism through insertional mutagenesis of fumarate hydratase (fumC) significantly impacts anaerobic growth . By extension, the fumarate reductase complex, including the frdD subunit, likely plays a similarly critical role in P. multocida's ability to adapt to oxygen-limited environments during infection.
When expressing recombinant P. multocida frdD, researchers must carefully consider the membrane-associated nature of this protein. Effective expression systems include:
E. coli-based systems with membrane protein optimization:
BL21(DE3) pLysS with C41/C43 derivatives specifically engineered for membrane protein expression
Codon-optimized constructs accounting for the different codon usage between P. multocida and E. coli
Fusion tags (such as maltose-binding protein) to enhance solubility while maintaining functionality
Cell-free expression systems:
Liposome-supplemented cell-free systems that provide a membrane-like environment
Nanodiscs incorporation for structural and functional studies
When expressing the recombinant protein, researchers should maintain the native hydrophobic character of frdD while incorporating appropriate purification tags. Expression conditions typically involve:
Induction at lower temperatures (16-20°C)
Extended expression periods (18-24 hours)
Reduced inducer concentrations to prevent formation of inclusion bodies
Storage in 50% glycerol with appropriate buffer composition (Tris-based) at -20°C or -80°C is recommended to maintain stability, with working aliquots kept at 4°C for up to one week to avoid freeze-thaw damage .
Given the membrane-integrated nature of frdD, specialized techniques are required:
Structural analysis:
Cryo-electron microscopy for whole complex visualization
Solid-state NMR for membrane-embedded structure determination
Hydrogen-deuterium exchange mass spectrometry to map membrane-spanning regions
Functional analysis:
Reconstitution in proteoliposomes to measure electron transfer activity
Membrane potential measurements using fluorescent probes
Oxygen consumption assays under varying oxygen tensions
Enzyme-coupled spectrophotometric assays monitoring fumarate reduction
Interaction studies:
Crosslinking mass spectrometry to identify interaction interfaces with other subunits
Native gel electrophoresis to assess complex formation
Blue native PAGE to analyze intact membrane protein complexes
When designing these experiments, researchers should include appropriate controls for membrane protein analysis and ensure that detergent selection during purification maintains the native conformation of the protein.
Verification of recombinant frdD functionality requires multiple approaches:
Complex assembly assessment:
Co-expression with other fumarate reductase subunits to verify proper complex formation
Sucrose gradient ultracentrifugation to isolate intact complexes
Western blotting to confirm co-purification of all subunits
Enzymatic activity:
Spectrophotometric assays tracking the conversion of fumarate to succinate
Monitoring quinol oxidation coupled to fumarate reduction
Comparison of kinetic parameters with native enzyme preparations
Membrane integration:
Carbonate extraction to confirm proper membrane association
Protease protection assays to verify correct topology
Fluorescence-based techniques to assess membrane insertion
A robust verification protocol should combine these approaches to ensure that the recombinant protein maintains both structural integrity and catalytic function comparable to the native complex.
The frdD gene in P. multocida is organized within an operon structure that coordinates the expression of all fumarate reductase subunits. Key genomic features include:
The frdD gene is designated as PM0198 in the P. multocida strain Pm70 genome
The fumarate reductase operon typically contains genes arranged in the order frdABCD
Regulatory elements include:
A promoter region responsive to anaerobic regulatory factors
FNR (fumarate and nitrate reduction) binding sites that activate transcription under low oxygen conditions
Potential binding sites for additional transcriptional regulators
The genomic organization ensures coordinated expression of all subunits in stoichiometric amounts, which is essential for proper complex assembly. Comparative genomic analysis shows that while the operon structure is conserved across Pasteurellaceae, subtle differences in regulatory elements may reflect host-specific adaptation patterns .
For effective genotyping and analysis of frdD across P. multocida strains, researchers should employ:
Whole genome sequencing approaches:
Short-read sequencing (Illumina) for high accuracy in sequence determination
Long-read sequencing (PacBio/Nanopore) for resolving complex genomic regions
Hybrid assembly approaches for complete genome reconstruction
Targeted sequencing methods:
PCR amplification with conserved primers followed by Sanger sequencing
MLST (Multilocus Sequence Typing) incorporating frdD as a marker gene
Restriction fragment length polymorphism (RFLP) analysis for rapid screening
Bioinformatic analysis tools:
Multiple sequence alignment to identify conserved and variable regions
Phylogenetic tree construction to establish evolutionary relationships
Selection pressure analysis to identify potential adaptive sites
Recent developments in P. multocida typing systems combine capsular, lipopolysaccharide, and MLST genotyping for comprehensive strain characterization. The PmGT platform represents an efficient tool for automated genotyping based on whole genome sequence data . While frdD itself is not typically included in standard typing schemes, analysis of its sequence can provide additional insights into strain relationships and host adaptation.
Several genetic manipulation strategies are available for studying frdD function:
Gene deletion and complementation:
Allelic exchange mutagenesis to create clean deletions
Suicide vector-based approaches for targeted gene replacement
Complementation with wild-type or modified alleles to verify phenotypes
Transposon mutagenesis systems:
Himar1 mariner mutagenesis system developed for Pasteurellaceae
Tn5-based systems for random insertional mutagenesis
Signature-tagged mutagenesis for high-throughput screening
Advanced genetic tools:
CRISPR-Cas9 systems adapted for P. multocida
Inducible expression systems to control frdD levels
Reporter gene fusions to study expression patterns
The application of Himar1 mariner vectors has proven effective for functional genomic analysis in Pasteurellaceae, including the identification of genes involved in anaerobic respiration pathways . For studying frdD specifically, researchers should consider the potential essentiality of this gene under anaerobic conditions and design conditional mutation strategies accordingly.
The contribution of frdD to P. multocida virulence stems from its role in anaerobic metabolism:
Adaptation to oxygen-limited host environments:
Respiratory tract infections (particularly deep tissue sites)
Abscesses and wound infections where oxygen is limited
Intracellular survival within phagocytes
Metabolic flexibility during infection:
Enables energy generation in diverse host microenvironments
Facilitates persistence during inflammatory responses
Supports growth when competition for oxygen is high
Host-specific adaptation patterns:
Sequence variations in frdD may reflect adaptation to different host species
Expression levels may vary depending on the infection site and host
While not a classical virulence factor like adhesins or toxins, the fumarate reductase complex contributes to pathogenesis by enabling metabolic adaptation. Studies of related Pasteurellaceae have shown that disruption of anaerobic respiration pathways can significantly impact virulence, suggesting that frdD and other components of fumarate respiration play important roles in bacterial survival during infection .
P. multocida exhibits host-specific strain distribution patterns that may reflect adaptations in metabolic genes like frdD:
| Host Source | Predominant Genotype | frdD Sequence Conservation | Notable Features |
|---|---|---|---|
| Avian | A:L1:ST128 | High within avian isolates | Adaptations for respiratory tract metabolism |
| Bovine | A:L3:ST1, B:L2:ST44 | High within bovine isolates | Variations may correlate with ruminal environment |
| Porcine | D:L6:ST11, A:L3:ST3 | Moderate variation | Specific substitutions in membrane-spanning regions |
| Leporine | A:L3:ST12 | High conservation | Limited data available |
| Human | A:L3:ST1, A:L1 | Similar to animal isolates | Zoonotic transmission maintains core functions |
Comparative analysis of P. multocida strains from different hosts shows that while core metabolic functions are preserved, subtle variations in frdD sequence and expression patterns may contribute to host adaptation . These variations may affect:
Efficiency of electron transfer under different host-specific conditions
Protein stability in different temperature ranges reflecting host body temperatures
Interaction with host-specific metabolites or inhibitors
Research approaches to investigate these differences should include comparative biochemical characterization of recombinant frdD from different host-adapted strains under conditions mimicking specific host environments.
To effectively study frdD function during infection, researchers should consider:
In vitro models:
Microaerobic and anaerobic culture systems
Host cell co-culture under controlled oxygen tensions
Biofilm formation assays to mimic in vivo growth conditions
Ex vivo models:
Precision-cut lung slices for respiratory infection studies
Primary cell cultures from relevant host species
Organ-on-chip systems incorporating tissue-specific factors
In vivo models:
Natural host challenge models when feasible
Mouse models with humanized or host-specific tissue factors
Comparative infection studies across multiple host species
Analytical approaches:
In vivo expression technology (IVET) to track frdD expression during infection
Dual RNA-seq to simultaneously monitor host and bacterial gene expression
Metabolomic analysis to assess changes in fumarate/succinate metabolism
Since P. multocida affects multiple host species, selection of appropriate experimental models should reflect the specific host-pathogen interaction being studied. Control of oxygen levels is particularly important when investigating anaerobic respiration genes like frdD, with oxygen-limited culture systems or tissue penetration models being especially relevant.
Structural analysis of frdD offers several opportunities for antimicrobial development:
Structure-based drug design:
Identification of druggable pockets at the interface between frdD and other subunits
Targeting of quinone binding sites that interact with the membrane subunits
Design of peptidomimetics that disrupt complex assembly
Comparative structural approaches:
Identifying structural differences between bacterial and mammalian succinate dehydrogenase/fumarate reductase
Exploiting unique features of the bacterial enzyme for selective targeting
Understanding species-specific structural variations for broad-spectrum activity
Rational design strategies:
Development of compounds that compete with menaquinol binding
Creation of molecules that disrupt the electron transfer pathway
Design of membrane-penetrating inhibitors that specifically target anaerobic respiration
High-resolution structural data combined with functional assays can guide development of compounds that specifically inhibit bacterial anaerobic respiration without affecting host metabolism. Since anaerobic respiration is critical for P. multocida persistence in tissues, such inhibitors could effectively reduce bacterial survival during infection.
Research on post-translational modifications of frdD is limited, but several regulatory mechanisms are likely involved:
Potential modifications:
Membrane integration may involve specific lipid interactions
Disulfide bond formation may stabilize protein conformation
Proteolytic processing might occur during membrane insertion
Expression regulation:
Oxygen-dependent transcriptional regulation via FNR or similar factors
Nitrate repression systems that coordinate different anaerobic pathways
Post-transcriptional regulation through RNA secondary structures
Environmental responsiveness:
pH-dependent conformational changes affecting complex activity
Temperature-responsive expression patterns
Nutrient availability signals that coordinate with central metabolism
Methodological approaches to study these aspects include:
Quantitative proteomics to identify modifications
Reporter gene fusions to monitor expression under varying conditions
Site-directed mutagenesis to assess the functional impact of potential modification sites
Understanding these regulatory mechanisms could provide insights into how P. multocida adapts its respiratory chain configuration in response to changing host environments.
Systems biology approaches offer powerful tools for understanding frdD within the broader metabolic network:
Metabolic modeling:
Genome-scale metabolic models incorporating anaerobic respiration pathways
Flux balance analysis to predict metabolic shifts under oxygen limitation
Integration of transcriptomic and proteomic data to refine model predictions
Network analysis:
Identification of metabolic bottlenecks in anaerobic respiration
Prediction of synthetic lethal interactions involving frdD
Multi-omics integration to map regulatory networks
Comparative systems approaches:
Cross-species metabolic models to identify conserved and divergent features
Host-pathogen interaction models incorporating metabolic exchanges
Ecological models of polymicrobial interactions
These approaches can reveal how fumarate reductase activity is integrated with other aspects of cellular metabolism, potentially identifying:
Alternative pathways that complement or compensate for frdD function
Critical nodes in metabolic networks that could serve as therapeutic targets
Metabolic adaptations that occur during host-specific infections
Several emerging technologies hold promise for advancing frdD research:
Advanced imaging techniques:
Cryo-electron tomography for visualizing membrane protein complexes in situ
Super-resolution microscopy to track frdD localization in bacterial cells
Correlative light and electron microscopy for functional-structural integration
High-throughput functional genomics:
CRISPR interference screening to identify genetic interactions
Transposon sequencing (Tn-Seq) under anaerobic conditions
Synthetic biology approaches to engineer optimized fumarate reductase complexes
Single-cell techniques:
Single-cell RNA-seq to identify subpopulations with differential frdD expression
Microfluidics-based approaches for real-time monitoring of metabolic shifts
Single-cell metabolomics to track metabolite fluctuations
Computational advances:
Artificial intelligence for protein structure prediction specific to membrane proteins
Molecular dynamics simulations of the entire fumarate reductase complex
Machine learning integration with experimental data for predictive modeling
These technologies could address current knowledge gaps regarding the dynamics of frdD expression, localization, and function during infection and adaptation to different host environments.
Research on frdD can provide insights into several fundamental aspects of bacterial biology:
Evolutionary adaptation:
Understanding selective pressures on respiratory chain components
Tracking horizontal gene transfer of respiratory modules across species
Identifying signatures of host adaptation in respiratory genes
Metabolic flexibility:
Elucidating mechanisms of respiratory chain remodeling
Understanding the balance between fermentation and anaerobic respiration
Mapping metabolic networks that enable survival in diverse environments
Host-pathogen co-evolution:
Tracking evolutionary changes in respiratory genes across host-adapted strains
Identifying patterns of convergent evolution in diverse pathogens
Understanding metabolic adaptations to specific host environments
By studying frdD in the context of P. multocida's adaptation to different hosts, researchers can gain insights into the evolutionary processes that shape bacterial metabolism and virulence. This research may reveal general principles applicable to other pathogens with broad host ranges.
Interdisciplinary collaboration offers opportunities for innovative frdD research:
Combining structural biology with synthetic chemistry:
Development of chemical probes specific to fumarate reductase components
Structure-guided design of inhibitors targeting the membrane subunits
Creation of photocrosslinking analogs to map protein-protein interactions
Integrating microbiology with systems immunology:
Understanding how anaerobic metabolism affects immune recognition
Mapping metabolic crosstalk between bacterial and host cells
Identifying immunomodulatory effects of bacterial respiratory byproducts
Merging microbial ecology with single-cell technologies:
Tracking respiratory gene expression in polymicrobial communities
Understanding competition for electron acceptors in infection sites
Mapping spatial distribution of respiratory activity in biofilms
Connecting veterinary medicine with comparative genomics:
Correlating frdD sequence variations with host range and virulence
Identifying host-specific patterns of anaerobic gene expression
Developing targeted treatments based on respiratory chain differences
These interdisciplinary approaches could reveal unexpected connections between anaerobic respiration, virulence, and host adaptation in P. multocida and related pathogens.